Google
CBUS — CIBUS GLOBAL LLC (Healthcare >> Biotechnology)
CBUS FAQ
What is CBUS's ROE?
CIBUS GLOBAL LLC reports a Return on Equity (ROE) of -285.85%.
What is CBUS's dividend yield?
CIBUS GLOBAL LLC offers a dividend yield of 0.00%.
What is CBUS's Deepscope Quality Score?
Deepscope rates CBUS's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CBUS?
Deepscope's AI Timing Score for CBUS is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CBUS belong to?
CIBUS GLOBAL LLC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 1.29
Price
-0.11
(-7.86%)
Day Change
|
|
|---|
CBUS, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.29 |
| PBV / Sector |
3.20 / 4.63
|
| Earning Per Share | -1.15 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.36 M
GREAT
|
| Average 1W Daily Value |
0.37 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
52% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:08:29 |
| Symbol | CBUS |
| Name | CIBUS GLOBAL LLC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 76.33 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 113.36 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6455 Nancy Ridge Drive, San Diego, CA, United States, 92121
Phone: 858 450 0008
Website: https://www.cibus.com
Employees: 118
Sector: Healthcare >> Biotechnology
Description: Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
